GR76535B - - Google Patents

Info

Publication number
GR76535B
GR76535B GR69402A GR820169402A GR76535B GR 76535 B GR76535 B GR 76535B GR 69402 A GR69402 A GR 69402A GR 820169402 A GR820169402 A GR 820169402A GR 76535 B GR76535 B GR 76535B
Authority
GR
Greece
Prior art keywords
image
group
relates
formula
antiepileptics
Prior art date
Application number
GR69402A
Other languages
English (en)
Inventor
Andre Hallot
Kathleen Biziere
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of GR76535B publication Critical patent/GR76535B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR69402A 1981-10-21 1982-09-29 GR76535B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119767A FR2514765A1 (fr) 1981-10-21 1981-10-21 Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
GR76535B true GR76535B (el) 1984-08-10

Family

ID=9263248

Family Applications (1)

Application Number Title Priority Date Filing Date
GR69402A GR76535B (el) 1981-10-21 1982-09-29

Country Status (24)

Country Link
US (1) US4499092A (el)
EP (1) EP0079810B1 (el)
JP (1) JPS5888369A (el)
KR (1) KR880001077B1 (el)
AT (1) ATE17576T1 (el)
AU (1) AU551938B2 (el)
CA (1) CA1236102A (el)
CS (1) CS229692B2 (el)
DD (1) DD210040A5 (el)
DE (1) DE3268699D1 (el)
DK (1) DK156063C (el)
ES (1) ES516694A0 (el)
FI (1) FI73982C (el)
FR (1) FR2514765A1 (el)
GR (1) GR76535B (el)
HU (1) HU187579B (el)
IE (1) IE53653B1 (el)
IL (1) IL66960A0 (el)
NO (1) NO164167C (el)
NZ (1) NZ202237A (el)
PT (1) PT75667B (el)
SU (1) SU1299511A3 (el)
YU (1) YU43528B (el)
ZA (1) ZA827516B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521144A1 (fr) * 1982-02-08 1983-08-12 Sanofi Sa Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
WO1994007498A1 (en) * 1992-10-07 1994-04-14 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical composition for inhibiting tumor necrosis factor production
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
AU2004236239A1 (en) * 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
WO2005042501A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
JP4769866B2 (ja) * 2005-06-27 2011-09-07 エフ．ホフマン−ラ ロシュ アーゲー クロロ置換グアニジン
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
BRPI0719111A8 (pt) 2006-11-22 2019-01-15 Sumitomo Chemical Co agente para inibir a sinalização de citocinina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA894239A (en) * 1972-02-29 Pfizer Inc. Nitrogen heterocycles
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3509141A (en) * 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation

Also Published As

Publication number Publication date
ZA827516B (en) 1983-08-31
IL66960A0 (en) 1983-02-23
NZ202237A (en) 1985-08-30
DE3268699D1 (en) 1986-03-06
HU187579B (en) 1986-01-28
CA1236102A (en) 1988-05-03
NO823491L (no) 1983-04-22
YU223382A (en) 1984-10-31
KR880001077B1 (ko) 1988-06-22
CS229692B2 (en) 1984-06-18
DK156063C (da) 1989-11-13
AU8962882A (en) 1983-04-28
YU43528B (en) 1989-08-31
EP0079810A1 (fr) 1983-05-25
ES8307226A1 (es) 1983-07-01
DD210040A5 (de) 1984-05-30
US4499092A (en) 1985-02-12
KR840001968A (ko) 1984-06-07
FI823580A0 (fi) 1982-10-20
ATE17576T1 (de) 1986-02-15
EP0079810B1 (fr) 1986-01-22
IE822447L (en) 1983-04-21
PT75667A (fr) 1982-11-01
NO164167C (no) 1990-09-05
DK465182A (da) 1983-04-22
AU551938B2 (en) 1986-05-15
FR2514765B1 (el) 1984-04-06
SU1299511A3 (ru) 1987-03-23
IE53653B1 (en) 1989-01-04
FI73982B (fi) 1987-08-31
PT75667B (fr) 1985-01-11
ES516694A0 (es) 1983-07-01
FI73982C (fi) 1987-12-10
FI823580L (fi) 1983-04-22
DK156063B (da) 1989-06-19
FR2514765A1 (fr) 1983-04-22
NO164167B (no) 1990-05-28
JPS5888369A (ja) 1983-05-26

Similar Documents

Publication Publication Date Title
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
ZA925783B (en) 5-Isoquinolinesulfonamides, process for preparing them and pharmaceutical compositions containing them.
AU3923789A (en) Diorganopolysiloxane derivatives, their preparation and their use
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
GR76535B (el)
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
IL87198A0 (en) Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them